The global prevalence of PNH is as high as 15.9 individuals per 1 million people. The annual global incidence of PNH is around 5 to 6 individuals per 1 million people. 5,6 In the United States, ...
Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...
Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...
Ongoing multinational basket trials are enrolling patients with relapsed or refractory disease. The US Food and Drug Administration has granted Fast Track designation to gamgertamig (OM336) for the ...
Efficacy analyses for the first 2 cohorts of the phase 1/2 studies will compare participant outcomes with those of a propensity score-matched external control group. AMT-130, an investigational gene ...
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare acquired autoimmune neurological disorder in which both T-cell-mediated and humoral immune mechanisms target healthy myelinated ...
Taylor Kane is executive director of Remember the Girls, a nonprofit group that advocates on behalf of females with X-linked disorders (Photo courtesy of Taylor Kane) New Jersey native Taylor Kane ...
Treatment with obexelimab compared with placebo was associated with a significantly longer time to the first IgG4-RD flare that required the use of rescue therapy (P .001). One hundred ninety-four ...
Sharon Hesterlee, PhD, who previously served as chief research officer at the MDA, has been named interim president and CEO. Donald S. Wood, PhD, has retired from the Muscular Dystrophy Association ...
Surgeons demonstrate the administration and use of Aytu BioPharma’s Healight endotracheal catheter system on a mechanically ventilated mannequin. Credit: Michael Lappen Aytu BioPharma has developed an ...
The modified Spinal Muscular Atrophy Functional Rating Scale (SMAFRS) is a psychometrically stable and unidimensional outcome measure, even though certain items are misfitting like those related to ...
From left: Samantha Masterson, president and CEO of the Myasthenia Gravis Foundation of America (MGFA); Angela Vincent, MBBS, winner of the MGFA’s first Lifetime Achievement Award; and Kevin O’Connor, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results